DVP
Develop Global Limited
🇦🇺 ASX
⛏️ MINING
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 282.86%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
34
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Develop Global Ltd. engages in the exploration and production of mine base and precious metal resources. The firm is also involved in operations of its underground mining services division Develop Mining Services Its segments include mining services and mining and exploration. The Company’s projects include Sulphur Springs Project, Whim Creek Joint Venture, Woodlawn Project, Pioneer Dome, and Kangan Gold Project. The Sulphur Springs project is located 144 kilometers (km) to the southeast of Port Hedland and includes the Sulphur Springs and Kangaroo Caves deposits together with tenements along the 27 km Panorama Trend that contains six advanced targets that have returned intersections of commercial grade copper and zinc. The Whim Creek Joint Venture Project is located 115 km to the southwest of Port Hedland. The Woodlawn Project is a zinc-copper-lead-gold-silver project located in the Lachlan Fold belt in New South Wales, 250 km south-west of Sydney and 40 km south of Goulburn.
📈 Performance
Price History
+42300.00%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$2.12
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in DVP
34
📊 Total Capital Earnings
$14K
🔃 Average investment frequency
32 weeks
💵 Average investment amount
$1,782
⏰ Last time a customer invested in DVP
17 days
DVP investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
21%
50k - 100k
42%
Less than 50k
26%
👶 Age of investors
18 - 25
15%
26 - 34
44%
35 - 90
41%
🙋 Legal gender of investors
Female
47%
Male
53%
Pearlers who invest in DVP also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.53%
📊 Share price
$101.72 AUD
🇦🇺 AUSTRALIA
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
IVV
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
20.53%
📊 Share price
$63.52 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
13.99%
📊 Share price
$140.06 AUD
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🌏 GLOBAL
🤖 TECHNOLOGY
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.77%
📊 Share price
$68.85 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
🙌 Performance (5Yr p.a)
13.71%
📊 Share price
$87.09 AUD
🌏 GLOBAL
🛍️ CONSUMER
📈 HIGH PRICE GROWTH
🏭 INDUSTRIALS
Want more shares? Try these...
Dimerix Ltd. engages in the investment of the research and development of biopharmaceutical drugs. The company is headquartered in Melbourne, Victoria. The firm is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. The company develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The firm is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets.
🙌 Performance (5Yr p.a)
28.46%
📊 Share price
$0.32 AUD
🧬 BIOTECHNOLOGY
📈 HIGH PRICE GROWTH
DVDY.AX was created on 2020-09-07 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars.
📊 Share price
$21.97 AUD
🏭 INDUSTRIALS
🇦🇺 AUSTRALIA
💸 FINANCIALS
DVL
dorsaVi Ltd. is a biotechnology company, which focuses on developing motion analysis device technologies for use in clinical practice, elite sports, and occupational health and safety. Its segments include Clinical and Workplace. The firm's products include Workplace Solutions, ViMove+, ViSafe, and Research+. Workplace Solution enables employers to assess risk of injury for employees as well as test the effectiveness of proposed changes to OHS workplace design, equipment or methods based on objective evidence. Its clinical solutions (ViMove, ViMove2 and Professional Suite) provides objective assessment, monitoring outside the clinic and immediate biofeedback. The clinical market is segmented into physical therapy (physiotherapists), hospital in the home, and elite sports. Hospital in the home refers to the remote management of patients by clinicians outside of physical therapy. Elite sports refer to the management and optimization of athletes through objective evidence.
🙌 Performance (5Yr p.a)
-9.84%
📊 Share price
$0.01 AUD
🩺 HEALTH CARE